C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) C12P 19/34 (2006.01) A61K 31/551 (2006.01)
Patent
CA 2542641
The present invention provides a method of predicting antipsychotic response to drug therapy comprising testing a sample obtained from a subject for the presence of a polymorphism in the dopamine D2 receptor gene DRD2, wherein the presence of the rs1079598T allele, the rs1125394A allele or both is predictive of the subject being susceptible to drug therapy.
Hwang Rudi
Kennedy James L.
Centre For Addiction And Mental Health
Gowling Lafleur Henderson Llp
LandOfFree
Dopamine d2 receptor gene variants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dopamine d2 receptor gene variants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dopamine d2 receptor gene variants will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2091107